×
About 743 results

ALLMedicine™ Bacterial Sepsis Center

Research & Reviews  269 results

Characterization of Secondary Bacterial Infections and Antibiotic Use in Mechanically V...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358424
Journal of Intensive Care Medicine; Risa E, Roach D et. al.

Aug 11th, 2021 - COVID-19 has a widely variable clinical syndrome that is difficult to distinguish from bacterial sepsis, leading to high rates of antibiotic use. Early studies indicate low rates of secondary bacterial infections (SBIs) but have included heterogen...

Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373392
Current Opinion in Rheumatology; Mehta P, Fajgenbaum DC

Jul 16th, 2021 - The COVID-19 pandemic is a global public health crisis with considerable mortality and morbidity. A role for cytokine storm and therapeutic immunomodulation in a subgroup of patients with severe COVID-19 was proposed early in the pandemic. The con...

Cathelicidin and PMB neutralize endotoxins by multifactorial mechanisms including LPS i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271772
Proceedings of the National Academy of Sciences of the Un... Schromm AB, Paulowski L et. al.

Jun 30th, 2021 - Antimicrobial peptides (AMPs) contribute to an effective protection against infections. The antibacterial function of AMPs depends on their interactions with microbial membranes and lipids, such as lipopolysaccharide (LPS; endotoxin). Hyperinflamm...

Comparison of renal histopathology and gene expression profiles between severe COVID-19...
https://doi.org/10.1186/s13054-021-03631-4
Critical Care (London, England); Volbeda M, Jou-Valencia D et. al.

Jun 12th, 2021 - The mechanisms driving acute kidney injury (AKI) in critically ill COVID-19 patients are unclear. We collected kidney biopsies from COVID-19 AKI patients within 30 min after death in order to examine the histopathology and perform mRNA expression ...

ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial PAI-1.
https://doi.org/10.1165/rcmb.2020-0544OC
American Journal of Respiratory Cell and Molecular Biology; Han M, Pandey D

May 19th, 2021 - Endothelial dysfunction is implicated in the thrombotic events reported in patients with coronavirus disease (COVID-19), but the underlying molecular mechanisms are unknown. Circulating levels of the coagulation cascade activator PAI-1 are substan...

see more →

Drugs  2 results see all →

News  26 results

Does COVID-19 Cause Sepsis?
https://www.medscape.com/viewarticle/939038

Oct 16th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection that can be bacterial, fungal, protozoal, or viral in origin, ...

Does COVID-19 Cause Sepsis?
https://www.staging.medscape.com/viewarticle/939038

Oct 16th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection that can be bacterial, fungal, protozoal, or viral in origin, ...

Unexpected Results in New COVID-19 'Cytokine Storm' Data
https://www.medscape.com/viewarticle/937044

Sep 8th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The immune system overactivation known as a "cytokine storm" does not play a major role in more severe COVID-19 outcomes, according to unexpected ...

PharMEDium Services Issues Voluntary Nationwide Recall of Specific Lots of Potassium Phosphate and Succinylcholine Chloride Due to a Lack of Sterility Assurance | FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pharmedium-services-issues-voluntary-nationwide-recall-specific-lots-potassium-phosphate-and

Summary Company Announcement Date: June 25, 2017 FDA Publish Date: February 07, 2018 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to Lack of Sterility Assurance Company Name: PharMEDium Services Brand Name: Brand Name...

Alvogen Issues Voluntary Nationwide Recall of Clindamycin Injection Due to a Potential for a Lack of Sterility Assurance | FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/alvogen-issues-voluntary-nationwide-recall-clindamycin-injection-due-potential-lack-sterility

Summary Company Announcement Date: June 16, 2017 FDA Publish Date: February 08, 2018 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to Lack of Sterility Assurance Company Name: Alvogen Brand Name: Brand Name(s) Alvogen ...

see more →